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Purpose/Objective: To demonstrate the feasibility of 
physician driven IMRT planning with a multicriteria 
optimization (MCO) treatment planning system. The long 
term objective is to involve physicians at an earlier stage of 
the treatment planning process in order to increase planning 
efficiency and allow physicians to more naturally express 
their clinical intentions. 
Materials and Methods: This treatment planning study is 
based on data of 10 prostate and 12 central nervous system 
(CNS) cases, previously treated at Massachusetts General 
Hospital with a clinically approved MCO-IMRT treatment plan, 
created by dosimetrists. MCO Pareto surfaces were 
recalculated using identical beam geometries as in the 
clinical plans. Physicians navigated to their preferred trade-
offs and created a deliverable plan (Figure 1). For each 
patient two plans, the clinically delivered and the physician 
navigated plan, are evaluated with regard to dosimetric 
differences and physician preference. Additionally the 




Results: Overall plans generated by dosimetrists versus 
physicians were comparative without marked differences. 
However, evaluation of individual treatment plans 
demonstrate different focuses of planning target volumes 
(PTV) and organs at risks (OAR) and between OARs, but not in 
a consistent way. While most of the evaluated quantities do 
not show significant deviations, general differences were 
found for the brainstem (p(D1)=0.029) in CNS, where the 
physician allowed higher values of D1, and for high dose 
regions of bladder (p(D1)=0.024, p(V65)=0.003) and rectum 
(p(D1)=0.005 , p(V65)=0.009), where the physician chose 
more OAR sparing in exchange for a lower PTV coverage 
(volume of 98%-isodose: p(V6527)=0.007). The full statistical 
evaluation and a blinded plan comparison survey of both 
plans are ongoing. After some introduction to the system, 
both physicians felt comfortable navigating and exploring the 
planning possibilities. A learning curve was observable 
throughout the study: physicians developed strategies and 
navigation times were reduced (prostate: from 30 to 5 
minutes, CNS: case specific variations 15-20 minutes). 
Recorded physicians statements such as: 'it is great to see the 
trade-offs' and 'isn't that interesting how much this dose is 
decreasing for a small increase in the other?' highlight that 
physicians put great value on being able to navigate their 
own plans.  
Conclusions: Physician driven planning by Pareto surface 
navigation is feasible. Generally physicians insight into the 
planning process is of great value. With respect to clinical 
decisions and planning efficiency the gain appears to be case 
and anatomical site dependent. 
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Purpose/Objective: To compare 3D-CRT and VMAT 
pancreatic radiotherapy planning, and to assess the 
feasibility of dose escalation. 
Materials and Methods: Fourteen pancreatic 4D-CT datasets 
were planned using: i) 5-7 field 3D-CRT, prescribing 54Gy in 
30 fractions, ii) double arc VMAT, prescribing 54Gy in 30 
fractions and iii) double arc VMAT, prescribing 59.4Gy in 33 
fractions. For 3D-CRT planning and VMAT planning to 54Gy, at 
least 98% of the PTV received ≥95% of the prescription dose 
(PD). For VMAT planning to 59.4Gy, areas of PTV overlap with 
the stomach and duodenum received ≥80% of the PD, and 95% 
of the non-overlapped PTV received ≥95% of the PD, as per 
the SCALOP II protocol. The Wilcoxon signed-rank test was 
used to compare dosimetric parameters. Spearman's 
correlations assessed correlations between volumes of PTV-
duodenal and PTV-stomach overlap, and dosimetric 
parameters. 
Results: It was necessary to exceed the duodenal V55Gy 
constraint (usual limit <1cc) in order to achieve coverage in 
six 3D-CRT plans. There was a strong correlation between the 
volume of PTV-duodenal overlap and duodenal V55Gy 
(Spearman's rho: 0.79, p=0.001). Where PTV-duodenal 
overlap exceeded 20cc, 3D-CRT plans could not be created 
without exceeding duodenal constraints. All duodenal 
constraints were met in all VMAT 54Gy and 59.4Gy plans.  
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It was necessary to exceed the stomach V50Gy constraint 
(usual limit <16cc) in order to achieve coverage in the five 
3D-CRT plans with the largest volumes of PTV-stomach 
overlap. There was a strong correlation between the volume 
of PTV-stomach overlap and stomach V50Gy (Spearman's rho: 
0.97, p<0.001). Stomach V50Gy was also exceeded in the five 
corresponding VMAT 54Gy plans. Where PTV-stomach overlap 
exceeded 15cc, then 3D-CRT and VMAT 54Gy plans could not 
be created without exceeding stomach constraints. The 
different coverage requirements, however, allowed all 
stomach constraints to be met in all but one VMAT 59.4Gy 
plans. Compared to 3D-CRT plans, VMAT 54Gy plans resulted 
in significant reductions in small bowel V50Gy, left and right 
kidney V20Gy, mean liver dose and duodenal V50Gy (Table 
1). There was a small but statistically significant increase in 
PTV mean dose with VMAT 54Gy compared to 3D-CRT (Table 
1) and there was, unsurprisingly, a significant increase in PTV 
mean dose when prescribing VMAT 59.4Gy compared to VMAT 





Conclusions: VMAT improved dose sculpting, thereby 
providing dosimetric advantages in several normal tissues and 
a potential solution in cases where constraints were not met 
using 3D-CRT. Volumes of PTV-duodenal and PTV-stomach 
overlap may be useful indicators as to the feasibility of 3D-
CRT planning. Because of lower coverage requirements in 
areas of PTV overlap, escalation to 59.4Gy using VMAT was 
feasible in most cases, facilitating higher mean PTV doses 
while still respecting normal tissue constraints.  
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Purpose/Objective: In 2008 we developed an off line set-up 
verification protocol for breast cancer patients with external 
skin markers [Van der Salm Radiother. Oncol. 90] using MV 
imaging, followed by online set-up correction in 2012 using 
KV imaging. However, we noticed an increase in skin reaction 
localized to the skin markers. Therefore we evaluated the 
feasibility of online setup correction with surgical clips 
evaluating dose coverage of breast and boost area. 
Materials and Methods: In 34 breast cancer patients an 
online set-up correction was performed using the external 
skin marker technique. Set-up correction was performed 
based on the match between a pair of orthogonal KV images 
with DRRs of the planning CT scan, based upon contoured 
skin markers and anatomical landmarks (eg. thoracic wall). In 
retrospect, all images were re-matched with DRRs with 
contoured surgical clips in the post-operative breast. In 
addition, for each patient 3 Cone Beam CTs (CBCT) were 
available. At first we investigated the migration of the 
surgical clips for set-up verification by measuring the inter-
clip distances at the beginning, middle and end of treatment 
on a CBCT with the planning CT as a reference. We then 
compared the setup as determined from the clips with that 
from our skin markers in 5 fractions for each patient (total 
170 fractions). Finally, we looked at the breast CTV coverage 
by recalculating the dose on the online setup corrected CBCT 
(including a re-contoured breast and boost CTV) with the 
patient setup according to both setup techniques. This 
coverage was compared with that of the treatment plan. 
Results: Almost all types of surgical clips could be well 
visualized: 4.7 (sd 0.7 range 3-6) clips per patient were 
available for analysis. Analysis of the interclip distance 
showed that the clip to center-of-mass (COM) distance 
decreased on average by 2 (sd 1) mm (absolute distance clip-
COM: 15(sd 8) mm). Differences between clip and marker 
setup were generally small (avg<0.3mm in all directions). The 
reconstructed dose distributions on the CBCT showed that the 
coverage (95% isodose) of the breast was 99% in the 
treatment plan, and remained 99% for the skin marker as well 
as for the surgical clip technique. Also the boost area 
coverage remained at 99% for both techniques and the 
treatment plan. Some differences in rotation (max 2 degr.) 
setup were observed between clip and skin marker 
technique, but in light of conservation of coverage those 
differences were indicated as not clinically relevant. 
Conclusions: The use of surgical clips for online position 
verification/correction using orthogonal-pair KV imaging 
results in as good target coverage as the use of skin markers, 
even though there is some migration of the clips. The use of 
surgical clips provides a simpler solution for position 
verification as compared to our skin markers, without the 
disadvantage of local increase of skin dose.  
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